Notebook - Inquiry 17
The State’s Tobacco Business
Counting harm when commercial and public responsibilities meet
- Health
- State enterprise
Working thesis
The strongest tobacco investigation separates modeled mortality, institutional incentives and responsibility for action.
A large number with a specific meaning
Evidence cutoff 2026-10-23 · Source refresh 2026-11-08 · 2 source records · 5 claim assessments
Section 01
A large number with a specific meaning
The Examination’s estimate attributes at least 57 million deaths to China Tobacco across 1990–2023. Its scale demands attention. Its meaning demands equal care: this is a modeled cumulative attribution, not an annual toll or a company-specific register of individually proven deaths.
The method combines population mortality estimates with a company allocation based on market share. That can make institutional scale visible where no single administrative record exists. It also introduces an assumption: a share of the market is used to allocate a share of harm. The calculation is not, by itself, a complete account of what would have happened if the firm had not existed.
Section 02
Inside the estimate
The cross-industry comparison adds another distinction. Tobacco’s market share is measured through product volume, while the method uses revenue for ultraprocessed food companies. Different proxies may be necessary, but they make the ranking conditional on methodological choices. The interactive explains those choices without pretending to reproduce the calculation.
The company-specific death total is a modeled attribution, not a register of individually adjudicated deaths.
Inspect each stage: population burden, company allocation, historical accumulation and the resulting estimate. The stages are an explanation of the published method. They are not independent measurements that can be adjusted freely. A slider with invented parameter ranges would create the appearance of sensitivity analysis without the underlying data needed to justify it.
Explore the evidence / estimate
Follow the ingredients and assumptions. These stages explain the published method; they do not recalculate it or supply an uncertainty interval.
Modeled input
Population burden
The starting point is population-level health estimation.
- Source family
- Global Burden of Disease
- Question
- What harm is included?
- Review
- Published method; no replication
Limit: Not a company-specific register.
Read every entry without selecting
Modeled input
Population burden
The starting point is population-level health estimation.
- Source family
- Global Burden of Disease
- Question
- What harm is included?
- Review
- Published method; no replication
Limit: Not a company-specific register.
Model assumption
Company allocation
The method allocates a share of harm to companies.
- Proxy for tobacco
- Volume
- Comparison proxy
- Food revenue
- Question
- How sensitive is the rank?
Limit: Allocation does not settle the counterfactual.
Cumulative period
Accumulation
The headline adds a historical burden across decades.
- Unit
- Modeled deaths across the period
- Annual figure
- Not supplied by this total
- Change over time
- Not established by a cumulative sum
Limit: Do not compare it as an annual toll.
Published estimate
Attributed result
A serious estimate whose meaning depends on its method.
- Claim type
- Modeled attribution
- Not claimed
- Individual legal causation
- Next question
- Institutional responsibility
Limit: Not independently reproduced by Mainland Dispatch.
Section 03
Responsibility after the calculation
The institutional question is how commercial interests meet public-health responsibilities. Ownership is part of the setting, but it does not establish the motive for a specific decision. A convincing explanation would trace authority, incentives and the ability to challenge a decision. The estimate supplies a reason to scrutinize those arrangements; it cannot supply the decision record itself.
There is a strong objection to methodological caution: uncertainty can become a way to postpone responsibility indefinitely. But precision need not have that effect. A bounded estimate can still describe a grave burden. Separating uncertainty about the exact allocation from the governance question makes scrutiny more specific, rather than making the harm disappear.
The reverse argument also matters. Public ownership could, in principle, create power to change commercial behavior as well as incentives to preserve it. Whether that capacity is used is an empirical question. The Notebook should examine decisions rather than assume that the ownership label alone answers how responsibility is exercised.
A replication could test whether the published arithmetic is reproducible; alternative inputs and assumptions could test how robust the result is. Those are different exercises, and neither has been performed here. The figure therefore keeps the published estimate, its period and its assumptions attached. Readers can examine the basis of the claim without being asked to mistake numerical precision for certainty about every dimension of responsibility.
Follow the reporting
Source explorer
Inspect who produced a record, what we accessed and what it can establish. Podcast pages and transcripts describe the available access; full audio listening is not implied. Related records may represent the same reporting.
2 of 2 records
The Examination · 2026-05-02
China Tobacco and the world’s deadliest company
Data investigation into tobacco mortality and a state-owned business.
primary-source / article / full-text
More than 57 million estimated deaths over 1990–2023 is modeled cumulative attribution, not annual mortality or individually adjudicated cases. Observed on 2026-10-23. Catalog inclusion is not independent verification.
The Examination · 2026-05-02
How we determined the world’s deadliest company
Methods companion explaining mortality estimates using disease burden and market share.
primary-source / article / full-text
Comparative ranking depends on attribution, historical market-share and disease-burden assumptions. Underlying model was not independently rerun. Observed on 2026-10-23. Catalog inclusion is not independent verification. Preserve company outreach and response status; nonresponse does not prove the model.
How to check this inquiry
Claims and limitations
Claim ledger and evidence relationships
- The Examination attributes at least 57 million deaths to China Tobacco over 1990–2023 through a model.
- reported · Cumulative modeled attribution, not an annual count or individual adjudication; not replicated here.
- direct support: How we determined the world’s deadliest company · Headline and methodology
- The method combines mortality estimates with company market-share allocation.
- reported · Allocation is an assumption, not a complete counterfactual of what would happen without the firm.
- direct support: How we determined the world’s deadliest company · Market-share explanation
- The method uses sales volume for tobacco and revenue for ultraprocessed food comparisons.
- reported · Cross-industry ranks are conditional on different allocation proxies.
- direct support: How we determined the world’s deadliest company · Volume and revenue proxy paragraphs
- Commercial interests and public-health duties require separate institutional scrutiny.
- analysis · Ownership does not by itself establish the motive for a particular decision.
- context: China Tobacco and the world’s deadliest company · Investigation as context
- The company-specific death total is a modeled attribution, not a register of individually adjudicated deaths.
- unresolved · The unsupported interpretation is a directly enumerated company death register, not the existence of the published estimate.
- context: How we determined the world’s deadliest company · Methodology qualification
Scope and review limitations
- Source-backed interpretation of records through 2026-10-23; publication review on 2026-11-08. Source claims are not independent findings.
- Podcast descriptions and available transcripts were inspected to the extent recorded; no complete audio listening is claimed.
- Authored paragraph references distinguish direct support, context and counter-evidence. Original reasoning, hypothetical examples and reporting proposals are explicitly distinguished in the prose.
- The company-specific death total is a modeled attribution, not a register of individually adjudicated deaths.